Innovative HIV Prevention and Treatment: Can a Twice-Yearly PrEP Injection Curb the HIV Pandemic?
Georgetown LawPlease join us for an in-depth discussion on Lenacapavir, a groundbreaking long-acting injectable PrEP formulation administered just twice a year. The speakers will examine Lenacapavir's potential to transform HIV prevention on […]